Shohami; Esther

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shohami; Esther.The latest application filed is for "novel arylated camphenes, processes for their preparation and uses thereof".

Company Profile

0.10.12

Shohami; Esther - Mevasseret Zion IL
Shohami; Esther - Mevaseret-Zion IL
Shohami; Esther - Jerusalem IL
Shohami; Esther - Mevassert Zion IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Arylated camphenes, processes for their preparation and uses thereof Grant 9,365,534 - Mechoulam , et al. June 14, 2	2016-06-14
Novel Arylated Camphenes, Processes For Their Preparation And Uses Thereof App 20150038728 - MECHOULAM; Raphael ; et al.	2015-02-05
Arylated camphenes, processes for their preparation and uses thereof Grant 8,722,938 - Mechoulam , et al. May 13, 2	2014-05-13
Uses Of Incensole, Incensole Acetate And Derivatives Thereof App 20130190393 - MOUSSAIEFF; Arik ; et al.	2013-07-25
Novel Arylated Camphenes, Processes For Their Preparation And Uses Thereof App 20120245366 - Mechoulam; Raphael ; et al.	2012-09-27
Methods Compositions And Article Of Manufacture For Modulating Bone Growth App 20100222438 - Bab; Itai ; et al.	2010-09-02
Methods compositions and articles of manufacture for modulating bone growth Grant 7,749,953 - Bab , et al. July 6, 2	2010-07-06
Uses Of Incensole, Incensole Acetate And Derivatives Thereof App 20100099756 - Moussaieff; Arik ; et al.	2010-04-22
Use of IL-18 inhibitors for treating head injuries Grant 7,655,616 - Shohami February 2, 2	2010-02-02
Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis Grant 7,407,753 - Zimmer , et al. August 5, 2	2008-08-05
Ras antagonists for treating neurodegenerative disorders App 20070054886 - Kloog; Yoel ; et al.	2007-03-08
Use of compositions that increase glutamate receptor activity in treatment of brain injury App 20060167099 - Biegon; Anat ; et al.	2006-07-27
Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis App 20050260608 - Zimmer, Andreas ; et al.	2005-11-24
Methods compositions and articles of manufacture for modulating bone growth App 20050137159 - Bab, Itai ; et al.	2005-06-23
Use of il-18 inhibitors for treating or preventing cns injuries App 20040191247 - Shohami, Esther	2004-09-30
Tumor necrosis factor alpha (TNF-.alpha.) inhibiting pharmaceuticals Grant 6,545,041 - Shohami , et al. April 8, 2	2003-04-08
Methods and compositions for the treatment of injury to the central nervous system Grant 6,475,998 - Soreq , et al. November 5, 2	2002-11-05
2-Arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-alpha and neuroprotector of brain in closed head injury App 20020072539 - Mechoulam, Raphael ; et al.	2002-06-13
Tumor necrosis factor alpha (TNF-alpha) inhibiting pharmaceuticals App 20020049245 - Shohami, Esther ; et al.	2002-04-25
Tumor necrosis factor alpha (TNF-.alpha.) inhibiting pharmaceuticals Grant 6,331,560 - Shohami , et al. December 18, 2	2001-12-18
Tumor necrosis factor .alpha. (TNF-.alpha.) inhibiting pharmaceuticals Grant 5,932,610 - Shohami , et al. August 3, 1	1999-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.